Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

News provided by

Feb 10, 2015, 12:57 ET

LONDON, Feb. 10, 2015 /PRNewswire/ -- Kalorama Information's Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products provides an analysis of all the key market segments involved in this industry, including products, equipment and testing.

There is an expanding market for human blood and blood components as a result of the growing and aging populations, particularly in the developed nations. While some countries such as India and the Philippines set prices for blood and blood components, in many of the developed nations including the U.S., there is no uniform, fixed price for blood. Rather, the cost varies from country to country and region to region, with even nearby centers often charging different prices and fluctuations often occurring.

Blood products covered in the report include:
Red Blood Cells (RBCs)
Immunoglobulins
Albumin
Other Plasma Products
Synthetic HBOC and PFC Agents
Recombinant Factors
Although the blood supplies in the developed nations are, to a very high degree, free of disease-causing viruses, the risk of transfusion-related infection is nonetheless present. Because these supplies contain human blood, achieving 100% virus eradication is unlikely. A variety of infectious agents can be present in blood, including viruses (e.g., HIV-1, hepatitis B and C, HTLV, West Nile virus), bacteria, protozoans, Chagas disease, Lyme Disease and prions (e.g., the agent of variant Crueutzfeldt-Jakob disease, which is the human form of mad cow disease). Nonetheless, blood safety is relatively high, due to the widespread usage of blood testing. As of 2014, the main residual risk is due to hepatitis B virus - ranging from 10 in Spain to 1.6 per million donations in France and Germany.

Testing markets covered include:
Blood Banking and Plasmapheresis Testing
Blood Typing
Human Immunodeficiency Virus (HIV) Testing
Hepatitis A Virus Testing
Hepatitis B Virus Testing
Hepatitis C Virus Testing
Human T-Cell Leukemia Virus Testing
West Nile Virus Testing
Other Safety Testing
High-blood-loss procedure estimates
Product pricing
Reimbursement rates
Products on the market and in development
The report also provides discussions of the key trends, as well as the regulatory, business, and clinical challenges facing the various sectors.

The report profiles key companies in the industry, including:
AABB
Abbott Laboratories
Akers Biosciences
America's Blood Centers
American Red Cross
Baxter International
Bayer AG
BD
BDI Pharma
Beckman Coulter
Beijing Tiantan Biological Products, Ltd.
Bharat Serums and Vaccines Ltd.
Bio-Rad Laboratories
Biotest Pharmaceuticals
BioTime Inc.
CHINA BIOLOGIC
CSL BEHRING
DiaSorin
Emergent Biosolutions
Ethicon Biosurgery
Fenwal/Fresenius Kabi
Gen-Probe Inc./Hologic
Grifols Biologicals, Inc.
HAEMONETICS, INC.
HUALAN BIOLOGICAL ENGINEERING
IMMUCOR
Kamada
Lanzhou Institute of Biological Products Nordisk
LFB
Micronics
Novo Nordisk A/S
Octapharma AG
OPK BioTech
ORTHO CLINICAL DIAGNOSTICS
Oxygen Biotherapeutics
Pfizer
ProMetic Biosciences
Reliance Life Sciences
Roche
Ronsen Pharma
Shanghai RAAS Blood Products Co., Ltd.
Shire plc
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Sinosource Biopharmaceutical, Inc.
Takeda
Terumo BCT
Walvax Biotechnology Co., Ltd.

Download the full report: https://www.reportbuyer.com/product/96699/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com